Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
DocMorris ( (CH:DOCM) ) has issued an announcement.
DocMorris reported that it met its 2025 revenue and earnings targets, delivering double-digit sales growth across all business areas while slightly improving adjusted EBITDA despite higher Rx marketing spend and ending the year with CHF 160 million in cash. The Germany segment, powered by strong prescription growth, rapid expansion in digital services and profitable telemedicine via TeleClinic, remains the main growth engine, while the Southern European marketplace posted modest revenue gains amid continued efforts to refine its marketing mix and sourcing.
The group sharpened its strategic shift toward an AI-first digital health platform through a new partnership with Google focused on an AI health companion, an AI-enabled pharmacy offering and operational efficiency, and it strengthened digital health leadership by appointing AI specialist Angeli Möller as Chief Digital Health Officer. DocMorris is also restructuring its logistics footprint by closing the Ludwigshafen site and consolidating operations in Heerlen to lift EBITDA from 2027, while simultaneously surpassing its 2030 CO2 reduction target and confirming its path to EBITDA breakeven in 2026 and free cash flow breakeven in 2027, albeit with reduced medium-term revenue growth ambitions and steady annual investment levels.
The most recent analyst rating on (CH:DOCM) stock is a Buy with a CHF12.00 price target. To see the full list of analyst forecasts on DocMorris stock, see the CH:DOCM Stock Forecast page.
More about DocMorris
DocMorris AG is a European digital health and e-pharmacy group focused on prescription (Rx) and over-the-counter medicines, telemedicine and healthcare marketplace services, with a core presence in Germany and Southern Europe. The company is expanding from a transaction-driven online pharmacy into an AI-supported digital health platform, leveraging assets such as TeleClinic and a leading healthcare retail media business to deepen customer engagement and improve profitability.
Average Trading Volume: 283,882
Technical Sentiment Signal: Strong Sell
Current Market Cap: CHF198.1M
See more insights into DOCM stock on TipRanks’ Stock Analysis page.